{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:34:31Z","timestamp":1763037271853,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.medmal.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T08:41:40Z","timestamp":1545640900000},"page":"231-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area"],"prefix":"10.1016","volume":"49","author":[{"given":"A.","family":"Bosch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Valour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Radenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pages-Ecochard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chidiac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Perpoint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Miailhes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Goutelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2018.11.013_bib0315","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1600-6143.2009.02894.x","article-title":"Mycobacterium tuberculosis in solid organ transplant recipients","volume":"9","author":"Subramanian","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0320","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0325","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.medmal.2018.11.013_bib0330","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0335","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/TP.0b013e3181ecea8d","article-title":"Tuberculosis in renal transplant recipients: the evidence for prophylaxis","volume":"90","author":"Currie","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.medmal.2018.11.013_bib0340","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/ajt.13235","article-title":"Incidence and risk factors for tuberculosis after liver transplantation in an endemic area: a nationwide population-based matched cohort study","volume":"15","author":"Chen","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0345","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/lt.23480","article-title":"Chemoprophylaxis with isoniazid in liver transplant recipients","volume":"18","author":"F\u00e1brega","year":"2012","journal-title":"Liver Transplant"},{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2018.11.013_bib0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0355","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medmal.2018.11.013_bib0360","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/cid\/cit488","article-title":"Challenging issues in tuberculosis in solid organ transplantation","volume":"57","author":"Horne","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0365","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1086\/597590","article-title":"Tuberculosis in solid organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology","volume":"48","author":"Aguado","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0370","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0375","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0380","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00007890-199408000-00008","article-title":"Tuberculosis in liver transplant patients","volume":"58","author":"Meyers","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.medmal.2018.11.013_bib0385","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00007890-200001150-00013","article-title":"Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens","volume":"69","author":"Meyers","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.medmal.2018.11.013_bib0390","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/TP.0b013e31828719c8","article-title":"Mycobacterium tuberculosis-associated immune reconstitution syndrome in solid organ transplant recipients","volume":"95","author":"Sun","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.medmal.2018.11.013_bib0395","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0400","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection\u00a0\u2013\u00a0United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.medmal.2018.11.013_bib0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3062.2011.00666.x","article-title":"Use of the QuantiFERON-TB Gold interferon gamma release assay for screening transplant candidates: a single-center retrospective study","volume":"14","author":"Theodoropoulos","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0410","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/lt.22319","article-title":"Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates","volume":"17","author":"Lyu","year":"2011","journal-title":"Liver Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0415","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00259-007-0585-0","article-title":"Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity","volume":"35","author":"Kim","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.medmal.2018.11.013_bib0420","doi-asserted-by":"crossref","first-page":"e1665","DOI":"10.1097\/MD.0000000000001665","article-title":"Liver transplantation in antituberculosis drugs-induced fulminant hepatic failure: a case report and review of the literature","volume":"94","author":"Li","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medmal.2018.11.013_bib0425","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medmal.2018.11.013_bib0430","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/civ156","article-title":"Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial","volume":"60","author":"Torre-Cisneros","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0435","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/cid\/civ639","article-title":"Tolerability of fluoroquinolones in management of latent tuberculosis in liver transplant candidates","volume":"61","author":"Tien","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0440","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/jac\/dku171","article-title":"Bedaquiline: a review of human pharmacokinetics and drug-drug interactions","volume":"69","author":"van Heeswijk","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.11.013_bib0445","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1248\/bpb.b14-00311","article-title":"Delamanid does not inhibit or induce cytochrome p450 enzymes in vitro","volume":"37","author":"Shimokawa","year":"2014","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.medmal.2018.11.013_bib0450","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1155\/2005\/287460","article-title":"The risk of tuberculosis transmission in solid organ transplantation: Is it more than a theoretical concern?","volume":"16","author":"Rose","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.medmal.2018.11.013_bib0455","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cmi.2015.03.010","article-title":"Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study","volume":"21","author":"Benito","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2018.11.013_bib0460","first-page":"333","article-title":"Transplantation-transmitted tuberculosis\u00a0\u2013\u00a0Oklahoma and Texas, 2007","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR"},{"key":"10.1016\/j.medmal.2018.11.013_bib0465","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.transproceed.2012.09.060","article-title":"Clinical features and outcomes of tuberculosis in solid organ transplant recipients","volume":"44","author":"Bodro","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.medmal.2018.11.013_bib0470","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40336-016-0164-0","article-title":"PET\/CT imaging of Mycobacterium tuberculosis infection","volume":"4","author":"Ankrah","year":"2016","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/j.medmal.2018.11.013_bib0475","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/lt.23903","article-title":"Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center","volume":"20","author":"Olithselvan","year":"2014","journal-title":"Liver Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0480","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199511000-00008","article-title":"Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients","volume":"60","author":"Ferrell","year":"1995","journal-title":"Transplantation"},{"year":"2011","series-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control","author":"National Collaborating Centre for Chronic Conditions (UK)","key":"10.1016\/j.medmal.2018.11.013_bib0485"},{"issue":"Suppl. 7","key":"10.1016\/j.medmal.2018.11.013_bib0490","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/1469-0691.12641","article-title":"Mycobacterial infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2018.11.013_bib0495","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/JCM.02268-10","article-title":"Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB\/RIF system","volume":"49","author":"Hillemann","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2018.11.013_bib0500","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.13.1.47","article-title":"Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease","volume":"13","author":"Acocella","year":"1972","journal-title":"Gut"},{"key":"10.1016\/j.medmal.2018.11.013_bib0505","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medmal.2018.11.013_bib0510","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.99.2.465","article-title":"Toxic hepatitis with isoniazid and rifampin. A meta-analysis","volume":"99","author":"Steele","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2018.11.013_bib0515","first-page":"256","article-title":"Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity","volume":"4","author":"Ohno","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0520","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/jhep.2002.32102","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis","volume":"35","author":"Huang","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.medmal.2018.11.013_bib0525","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","article-title":"NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy","volume":"69","author":"Azuma","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.medmal.2018.11.013_bib0530","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00002018-200225020-00005","article-title":"Clinically significant interactions with drugs used in the treatment of tuberculosis","volume":"25","author":"Yew","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.medmal.2018.11.013_bib0535","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/AAC.18.5.661","article-title":"Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid","volume":"18","author":"Sarma","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2018.11.013_bib0540","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","volume":"74","author":"Alsultan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.medmal.2018.11.013_bib0545","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.13.5.366","article-title":"Effect of rifampicin on liver function in man","volume":"13","author":"Capelle","year":"1972","journal-title":"Gut"},{"key":"10.1016\/j.medmal.2018.11.013_bib0550","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000221455","article-title":"Studies on blood serum levels of rifampicin in patients with normal and impaired liver function","volume":"19","author":"Curci","year":"1973","journal-title":"Chemotherapy"},{"key":"10.1016\/j.medmal.2018.11.013_bib0555","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin: clinical relevance","volume":"42","author":"Niemi","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2018.11.013_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2012.747952","article-title":"Update on rifampin, rifabutin, and rifapentine drug interactions","volume":"29","author":"Baciewicz","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.medmal.2018.11.013_bib0565","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/infdis\/jit352","article-title":"Serum drug concentrations predictive of pulmonary tuberculosis outcomes","volume":"208","author":"Pasipanodya","year":"2013","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.medmal.2018.11.013_bib0570","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/clinids\/22.Supplement_1.S15","article-title":"The clinical pharmacokinetics of rifabutin","volume":"22","author":"Blaschke","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.medmal.2018.11.013_bib0575","first-page":"S263","article-title":"Interactions between antiinfective agents and immunosuppressants","volume":"9","author":"Thomas","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.medmal.2018.11.013_bib0580","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/jac\/dkw024","article-title":"Rifabutin: where do we stand in 2016?","volume":"71","author":"Crabol","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2018.11.013_bib0585","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/429321","article-title":"Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis","volume":"40","author":"Weiner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0590","first-page":"76","article-title":"Pharmacokinetics of pyrazinamide and its metabolites in patients with hepatic cirrhotic insufficiency","volume":"40","author":"Lacroix","year":"1990","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.medmal.2018.11.013_bib0595","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/599040","article-title":"Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana","volume":"48","author":"Chideya","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0600","first-page":"1318","article-title":"Ethambutol dosage for the treatment of children: literature review and recommendations","volume":"10","author":"Donald","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.medmal.2018.11.013_bib0605","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003088-200140030-00003","article-title":"Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials","volume":"40","author":"Aminimanizani","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2018.11.013_bib0610","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.medmal.2018.11.013_bib0615","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0168-8278(99)80325-0","article-title":"Antecedent liver disease and drug toxicity","volume":"31","author":"Schenker","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.medmal.2018.11.013_bib0620","first-page":"796","article-title":"Role of individual drugs in the chemotherapy of tuberculosis","volume":"4","author":"Mitchison","year":"2000","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17310417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X17310417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:17:14Z","timestamp":1759972634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X17310417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0399077X17310417"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2018.11.013","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}